NM_080683.3:c.661G>C

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_080683.3(PTPN13):​c.661G>C​(p.Asp221His) variant causes a missense change. The variant allele was found at a frequency of 0.000000694 in 1,441,386 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D221G) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 6.9e-7 ( 0 hom. )

Consequence

PTPN13
NM_080683.3 missense

Scores

2
6
11

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 5.67

Publications

0 publications found
Variant links:
Genes affected
PTPN13 (HGNC:9646): (protein tyrosine phosphatase non-receptor type 13) The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP is a large intracellular protein. It has a catalytic PTP domain at its C-terminus and two major structural domains: a region with five PDZ domains and a FERM domain that binds to plasma membrane and cytoskeletal elements. This PTP was found to interact with, and dephosphorylate, Fas receptor and IkappaBalpha through the PDZ domains. This suggests it has a role in Fas mediated programmed cell death. This PTP was also shown to interact with GTPase-activating protein, and thus may function as a regulator of Rho signaling pathways. Four alternatively spliced transcript variants, which encode distinct proteins, have been reported. [provided by RefSeq, Oct 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.23466203).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PTPN13NM_080683.3 linkc.661G>C p.Asp221His missense_variant Exon 7 of 48 ENST00000411767.7 NP_542414.1 Q12923-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PTPN13ENST00000411767.7 linkc.661G>C p.Asp221His missense_variant Exon 7 of 48 1 NM_080683.3 ENSP00000407249.2 Q12923-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
6.94e-7
AC:
1
AN:
1441386
Hom.:
0
Cov.:
30
AF XY:
0.00
AC XY:
0
AN XY:
715504
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32338
American (AMR)
AF:
0.00
AC:
0
AN:
41032
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25024
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39542
South Asian (SAS)
AF:
0.00
AC:
0
AN:
81912
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52834
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5630
European-Non Finnish (NFE)
AF:
9.06e-7
AC:
1
AN:
1103580
Other (OTH)
AF:
0.00
AC:
0
AN:
59494
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.625
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Aug 30, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.661G>C (p.D221H) alteration is located in exon 7 (coding exon 6) of the PTPN13 gene. This alteration results from a G to C substitution at nucleotide position 661, causing the aspartic acid (D) at amino acid position 221 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Uncertain
0.044
T
BayesDel_noAF
Benign
-0.18
CADD
Uncertain
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.095
.;.;.;T;.
Eigen
Uncertain
0.66
Eigen_PC
Pathogenic
0.67
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Uncertain
0.93
D;D;D;D;.
M_CAP
Benign
0.040
D
MetaRNN
Benign
0.23
T;T;T;T;T
MetaSVM
Benign
-0.84
T
MutationAssessor
Benign
2.0
M;M;M;M;M
PhyloP100
5.7
PrimateAI
Benign
0.47
T
PROVEAN
Benign
-2.1
N;N;N;N;N
REVEL
Benign
0.13
Sift
Uncertain
0.0010
D;D;D;D;D
Sift4G
Uncertain
0.0050
D;D;D;D;D
Polyphen
1.0
D;D;P;D;D
Vest4
0.41
MutPred
0.27
Gain of sheet (P = 0.0036);Gain of sheet (P = 0.0036);Gain of sheet (P = 0.0036);Gain of sheet (P = 0.0036);Gain of sheet (P = 0.0036);
MVP
0.51
MPC
0.25
ClinPred
0.94
D
GERP RS
5.5
Varity_R
0.23
gMVP
0.35
Mutation Taster
=66/34
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1731124289; hg19: chr4-87622420; API